BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28292007)

  • 1. Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents.
    Seo N; Park MS; Han K; Lee KH; Park SH; Choi GH; Choi JY; Chung YE; Kim MJ
    Cancer Res Treat; 2018 Jan; 50(1):60-70. PubMed ID: 28292007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
    Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
    Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
    Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
    Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
    J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
    Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
    Sofue K; Tsurusaki M; Murakami T; Onoe S; Tokue H; Shibamoto K; Arai Y; Sugimura K
    Eur Radiol; 2014 Oct; 24(10):2532-9. PubMed ID: 24865698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.
    Koh DM; Collins DJ; Wallace T; Chau I; Riddell AM
    Br J Radiol; 2012 Jul; 85(1015):980-9. PubMed ID: 22167501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
    Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
    Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer.
    Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W
    World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.